A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors (Q33441248)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors |
scientific article |
Statements
1 reference
A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors (English)
1 reference
Franck Bourdeaut
1 reference
Birgit Geoerger
1 reference
Steven G DuBois
1 reference
Matthias Fischer
1 reference
James I Geller
1 reference
Nicholas G Gottardo
1 reference
Andrew D J Pearson
1 reference
Thomas Cash
1 reference
Marlyane Motta
1 reference
Alessandro Matano
1 reference
Suraj G Bhansali
1 reference
Jason R Dobson
1 reference
Sudha Parasuraman
1 reference
Susan N Chi
1 reference
1 reference
1 reference
Identifiers
1 reference